Survival Benefits of Metformin for Colorectal Cancer Patients With Diabetes: A Systematic Review and Meta-Analysis

PLoS ONE - United States
doi 10.1371/journal.pone.0091818
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Metformin Use Improves Survival of Diabetic Liver Cancer Patients: Systematic Review and Meta-Analysis

Oncotarget
Oncology
2016English

Survival Benefits From Follow-Up of Patients With Lung Cancer: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Metformin Use and Survival Outcomes in Endometrial Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

Risk of Colorectal Cancer in Asian Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2017English

Metformin, Diabetes, and Survival Among U.S. Veterans With Colorectal Cancer—Response

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2017English

P3.04-19 Do Advanced Lung Cancer Patients Derive Similar Survival Benefits From Immunotherapy? A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Palliative Chemotherapy for Advanced Colorectal Cancer: Systematic Review and Meta-Analysis

Annales de Chirurgie
2003English

Autoantibodies as Biomarkers for Colorectal Cancer: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2019English

Prognostic Value of Lymph Node Yield on Long-Term Survival in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy